Lu Hongbo (CIK 0001767584)

Latest company ownership

Shares held
476,190
Last filed at
Sep 17, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q3 2025Q4
Shares held
321,983
Last filed at
Oct 9, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
47,163
Last filed at
Dec 20, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 13, 2024 Oct 9, 2025 Zenas BioPharma, Inc. Director Buy 100.0 +321,983 100.00% ✗ $6M
Mar 22, 2024 Nov 15, 2024 ARROWHEAD PHARMACEUTICALS, INC. Director Buy 22.5 -3,250 -8.26% ✗ $62.2K
Sep 13, 2024 Sep 17, 2024 Zenas BioPharma, Inc. Director Buy 97.5 +58,823 100.00% ✗ $1000K
Sep 12, 2024 Sep 17, 2024 Terns Pharmaceuticals, Inc. Director Buy 100.0 +476,190 100.00% ✗ $5M
Mar 18, 2024 Mar 20, 2024 ARROWHEAD PHARMACEUTICALS, INC. Director Buy 90.0 +3,000 9.78% ✗ $83K
Dec 23, 2022 Dec 23, 2022 Terns Pharmaceuticals, Inc. Director Buy 100.0 +758,620 21.18% ✗ $5.5M
Sep 7, 2022 Sep 8, 2022 Terns Pharmaceuticals, Inc. Director Buy 100.0 +600,000 20.12% ✗ $2.2M
Aug 12, 2022 Aug 16, 2022 Terns Pharmaceuticals, Inc. Director Buy 100.0 +2,624,239 734.35% ✗ $7M